Legis Daily

Designating the week of May 1, 2022, through May 7, 2022, as "Tardive Dyskinesia Awareness Week".

USA117th CongressHRES-1107| House 
| Updated: 5/11/2022
Scott H. Peters

Scott H. Peters

Democratic Representative

California

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This resolution supports the designation of Tardive Dyskinesia Awareness Week. Tardive dyskinesia is a movement disorder characterized by involuntary and uncontrolled movements of muscles in the face, torso, and extremities. It is caused by prolonged use of certain medications, including ones used to treat schizophrenia.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 8, 2021

Latest Companion Bill Action

SRES 117-184
Passed/agreed to in Senate: Resolution agreed to in Senate without amendment and with a preamble by Unanimous Consent.(text: 4/28/2021 CR S2297-2298)
May 11, 2022
Introduced in House
May 11, 2022
Referred to the House Committee on Energy and Commerce.
  • June 8, 2021

    Latest Companion Bill Action

    SRES 117-184
    Passed/agreed to in Senate: Resolution agreed to in Senate without amendment and with a preamble by Unanimous Consent.(text: 4/28/2021 CR S2297-2298)


  • May 11, 2022
    Introduced in House


  • May 11, 2022
    Referred to the House Committee on Energy and Commerce.

Health

Related Bills

  • SRES 117-184: A resolution designating the week of May 2, 2021, through May 8, 2021, as "Tardive Dyskinesia Awareness Week".
Commemorative events and holidaysDrug therapyHealth promotion and preventive careMental healthNeurological disorders

Designating the week of May 1, 2022, through May 7, 2022, as "Tardive Dyskinesia Awareness Week".

USA117th CongressHRES-1107| House 
| Updated: 5/11/2022
This resolution supports the designation of Tardive Dyskinesia Awareness Week. Tardive dyskinesia is a movement disorder characterized by involuntary and uncontrolled movements of muscles in the face, torso, and extremities. It is caused by prolonged use of certain medications, including ones used to treat schizophrenia.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 8, 2021

Latest Companion Bill Action

SRES 117-184
Passed/agreed to in Senate: Resolution agreed to in Senate without amendment and with a preamble by Unanimous Consent.(text: 4/28/2021 CR S2297-2298)
May 11, 2022
Introduced in House
May 11, 2022
Referred to the House Committee on Energy and Commerce.
  • June 8, 2021

    Latest Companion Bill Action

    SRES 117-184
    Passed/agreed to in Senate: Resolution agreed to in Senate without amendment and with a preamble by Unanimous Consent.(text: 4/28/2021 CR S2297-2298)


  • May 11, 2022
    Introduced in House


  • May 11, 2022
    Referred to the House Committee on Energy and Commerce.
Scott H. Peters

Scott H. Peters

Democratic Representative

California

Energy and Commerce Committee

Health

Related Bills

  • SRES 117-184: A resolution designating the week of May 2, 2021, through May 8, 2021, as "Tardive Dyskinesia Awareness Week".
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Commemorative events and holidaysDrug therapyHealth promotion and preventive careMental healthNeurological disorders